Table 3 |
|||
|
Baseline Demographics and Clinical Characteristics, by Bleeding-related Complication and/or Blood Product Transfusion Status |
|||
|
Characteristic |
Complication* |
No Complication |
P-value |
|
|
|||
|
Number of patients |
351,065 |
1,175,208 |
|
|
Age, mean years (SD) |
64.0 (17.9) |
55.1 (18.7) |
< 0.001 |
|
Range |
1-89 |
1-89 |
|
|
Male, N (%) |
159,893 (45.5%) |
432,211 (36.8%) |
< 0.001 |
|
Race, N (%) |
|||
|
White |
231,146 (65.8%) |
770,920 (65.6%) |
< 0.001 |
|
Black |
46,288 (13.2%) |
143,269 (12.2%) |
|
|
Hispanic |
12,842 (3.7%) |
58,358 (5.0%) |
|
|
Other |
60,789 (17.3%) |
202,661 (17.2%) |
|
|
Geographic Region, N (%) |
|||
|
Northeast |
57,899 (16.5%) |
163,160 (13.9%) |
< 0.001 |
|
South |
170,133 (48.5%) |
537,047 (45.7%) |
|
|
Midwest |
60,598 (17.3%) |
259,391 (22.1%) |
|
|
West |
58,970 (16.8%) |
204,439 (17.4%) |
|
|
Unknown |
3,465 (1.0%) |
11,171 (1.0%) |
|
|
Primary Payer, N (%) |
|||
|
Medicare |
202,495 (57.7%) |
443,685 (37.8%) |
< 0.001 |
|
Medicaid |
24,477 (7.0%) |
110,654 (9.4%) |
|
|
Private |
98,132 (28.0%) |
524,710 (44.6%) |
|
|
Uninsured |
13,495 (3.8%) |
45,219 (3.8%) |
|
|
Other |
12,466 (3.6%) |
50,940 (4.3%) |
|
|
Comorbidity, N (%) |
|||
|
Diabetes |
162,097 (46.2%) |
306,512 (26.1%) |
< 0.001 |
|
Obesity |
41,646 (11.9%) |
150,510 (12.8%) |
< 0.001 |
|
COPD |
88,506 (25.2%) |
219,635 (18.7%) |
< 0.001 |
|
Cancer |
80,506 (22.9%) |
198,206 (16.9%) |
< 0.001 |
|
Cirrhosis |
11,034 (3.1%) |
9,835 (0.8%) |
< 0.001 |
|
Prior Hospitalization, N (%) |
161,956 (46.1%) |
486,348 (41.4%) |
< 0.001 |
|
Prior Surgery, N (%) |
106,064 (30.2%) |
293,533 (25.0%) |
< 0.001 |
|
Pre-operative use of substances that promote hemostasis, N (%) |
7,957 (2.3%) |
21,338 (1.8%) |
< 0.001 |
|
|
|||
|
N = number of patients, SD = standard deviation *Bleeding complication and/or blood product transfusion |
|||
|
Stokes et al. BMC Health Services Research 2011 11:135 doi:10.1186/1472-6963-11-135 |
|||
